| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/10/2007 | US7201914 May contain a viricide, a bactericide or bacteriostate, and/or an antiinflammatory agent; uses include control of microbial growth on gloved hands |
| 04/10/2007 | US7201896 IL6RIL6 chimera for the treatment of neurodegenerative diseases |
| 04/10/2007 | CA2473370C Method for decreasing bioprosthetic implant failure |
| 04/10/2007 | CA2470066C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2403869C Method for treating dry eye |
| 04/10/2007 | CA2389896C Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 04/10/2007 | CA2202170C Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna) |
| 04/10/2007 | CA2199844C Compositions for the treatment of skin disorders |
| 04/10/2007 | CA2135608C Contraception using competitive progesterone antagonists, and novel compounds useful therefor |
| 04/05/2007 | WO2007038551A2 Use of ibudilast for treating drug and behavioral addictions |
| 04/05/2007 | WO2007038212A1 ADENOSINE A2a RECEPTOR ANTAGONISTS FOR THE TREATMENT OF EXTRA-PYRAMIDAL SYNDROME AND OTHER MOVEMENT DISORDERS |
| 04/05/2007 | WO2007038073A2 Mutations and polymorphisms of hdac11 |
| 04/05/2007 | WO2007037667A1 Pharmaceutical form for the treatment of patients with acute cases and exacerbations of rheumatoid arthritis and related acute disorders |
| 04/05/2007 | WO2007037560A1 Therapeutic or diagnostic application of sgk2 gene |
| 04/05/2007 | WO2007037555A1 Therapeutic or diagnostic application of dusp15 gene |
| 04/05/2007 | WO2007037550A1 Therapeutic or diagnostic application of tsta3 gene |
| 04/05/2007 | WO2007037543A1 Biarylamide derivative |
| 04/05/2007 | WO2007037538A1 Therapeutic or diagnostic application of spo11 gene |
| 04/05/2007 | WO2007037533A1 Therapeutic or diagnostic application of ppp1r3d gene |
| 04/05/2007 | WO2007037532A1 Therapeutic or diagnostic application of srms gene |
| 04/05/2007 | WO2007037473A1 Method of inhibiting cell migration and cell migration inhibitor |
| 04/05/2007 | WO2007037333A1 Inhibitor of binding to non-typical proline-rich sequence |
| 04/05/2007 | WO2007037299A1 Substance inhibiting the expression of hb24 or the transcriptional regulatory activity thereof, use of the same and method of screening the substance |
| 04/05/2007 | WO2007037296A1 Medical agent containing insulin resistance improving agent |
| 04/05/2007 | WO2007037133A1 Method for evaluation of compound capable of acting on plk3 |
| 04/05/2007 | WO2007036920A2 Therapeutic use of polyanhydroglucronic acid |
| 04/05/2007 | WO2006128674A3 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases |
| 04/05/2007 | WO2006124684A3 Combination therapy comprising a taxane and a thymidylate synthase inhibitor |
| 04/05/2007 | WO2006110491A3 Complementary compositions to reduce blood glucose levels and treat diabetes |
| 04/05/2007 | WO2006109195A3 Modulation of an immune response by filamentous haemagglutinin |
| 04/05/2007 | WO2006096626A3 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 04/05/2007 | WO2006025767A8 Perorally administrable antimicrobial composition |
| 04/05/2007 | WO2005067969A3 Combinations of serotonin reuptake inhibitors and imidazoline-i2-agonists |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078188 Compositions comprising and methods of using norfluoxetine |
| 04/05/2007 | US20070078106 A 5-substituted uracil or 5,6-dihydro-5-substituted uracil, potentiate 5-fluorouracil; 5-substituent is selected from bromo, ido, cyano, halo-substituted C1-4 alkyl, C2-6 alkenyl, 1-halo-C2-6 alkenyl andhalo-substituted C2-6 alkynyl; antitumor agents; anticarcinogenic agents |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070078091 Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate |
| 04/05/2007 | US20070078088 Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480, 20893, 33230, 1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules |
| 04/05/2007 | US20070078084 Compositions and methods related to production of erythropoietin |
| 04/05/2007 | US20070077288 Transdermal delivery of non-steroidal anti-inflammatory drugs |
| 04/05/2007 | US20070077273 Microfabricated nanopore device for sustained release of therapeutic agent |
| 04/05/2007 | US20070077232 Conditioned cell culture medium compositions and methods of use |
| 04/05/2007 | US20070077225 Continuous delivery methods for treating hepatitis virus infection |
| 04/05/2007 | US20070077208 Pharmaceutical foam |
| 04/05/2007 | DE60210604T2 Polymer-kontrolliertes induziertes viskoses ballaststoffsystem und dessen verwendungen Polymer controlled induced viscous fiber system and uses its |
| 04/05/2007 | DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen |
| 04/05/2007 | CA2623764A1 Modulation of tlr-mediated immune responses using adaptor oligonucleotides |
| 04/05/2007 | CA2623072A1 Use of ibudilast for treating drug and behavioral addictions |
| 04/05/2007 | CA2623040A1 Adenosine a2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 04/05/2007 | CA2609618A1 Novel acetylsalicylic acid formulations |
| 04/04/2007 | WO2007041637A2 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 04/04/2007 | EP1769821A1 Applicator for the delivery of topical formulations into mucosal cavities |
| 04/04/2007 | EP1769807A1 Graft rejection suppressors |
| 04/04/2007 | EP1769805A1 Therapeutic modulation of the tumor inflammatory response |
| 04/04/2007 | EP1769799A2 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 04/04/2007 | EP1769797A2 Methods and compositions using cetirizine in combination with leukotriene Inhibitors for treating conditions responsive to leukotriene inhibitiion |
| 04/04/2007 | EP1769795A2 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 04/04/2007 | EP1769785A1 Dermal penetration enhancers and drug delivery systems involving same |
| 04/04/2007 | EP1768748A2 Compositions comprising strontium and vitamin d and uses thereof |
| 04/04/2007 | EP1768699A1 Induction of apoptosis in toll-like receptor expressing tumor cells |
| 04/04/2007 | EP1768686A2 Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use |
| 04/04/2007 | EP1768679A1 MODULATION OF GSK-3&bgr; AND METHOD OF TREATING PROLIFERATIVE DISORDERS |
| 04/04/2007 | EP1768676A1 Use of compounds containing thiol groups as an efflux pump inhibitor |
| 04/04/2007 | EP1768662A2 Small molecule immunopotentiators and assays for their detection |
| 04/04/2007 | EP1768602A2 Combination drug therapy for reducing scar tissue formation |
| 04/04/2007 | EP1545546B1 Treatment of dyskinesia with 2,3-benzodiazepines |
| 04/04/2007 | EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 04/04/2007 | EP1401422B1 Halogenated composition, method for preparing same and uses thereof |
| 04/04/2007 | EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/04/2007 | EP1352056B1 Polypeptides capable of eliciting an immune reaction against cancer |
| 04/04/2007 | EP1345608B1 Selective dopamine d4 receptor agonists for treating sexual dysfunction |
| 04/04/2007 | EP1331932B1 Use of xestospongin c for treating or preventing hiv infection |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | EP1239861B1 Combination of cyamemazine and an atypical neuroleptic |
| 04/04/2007 | EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 04/04/2007 | EP1226256B1 Recombinant bifunctional fusion proteins for the clearance of variable viruses |
| 04/04/2007 | EP1098642B1 Diamino-propanol-compounds for treating ischemia |
| 04/04/2007 | EP0980203B1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 04/04/2007 | EP0969835B1 Use of central cannabinoid receptor antagonists for regulating appetency |
| 04/04/2007 | EP0951292B1 Treating an ischemic disorder and improving stroke outcome |
| 04/04/2007 | CN1942472A Reverse-turn mimetics and method relating thereto |
| 04/04/2007 | CN1942197A Method for improved breast milk feeding to reduce the risk of allergy |
| 04/04/2007 | CN1942184A Niosame having metal porphyrin complex embedded therein, process for it and drug with use thereof |
| 04/04/2007 | CN1942179A Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders |
| 04/04/2007 | CN1942162A Antimicrobial formulations and methods of using the same |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939540A Medicine composition containing insulin sensibilizer and B-family vatamines |
| 04/04/2007 | CN1939539A Local prescription for wart, nail-disease treatment and nail care |
| 04/04/2007 | CN1939538A Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 04/04/2007 | CN1939531A Use of botulinum toxin for the treatment of unstable bladder |
| 04/04/2007 | CN1939299A Combinations comprising epothilone derivatives and alkylating agents |
| 04/04/2007 | CN1939278A Methods for providing oxidatively stable ophthalmic compositions |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/04/2007 | CN1308038C Novel combination of glucocorticoids and PDG-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD |
| 04/04/2007 | CN1307998C Novel method and compositions for local treatment of Meniere's disease, tinnitus and hearing loss |
| 04/04/2007 | CN1307992C Eye drops containing tetrazole derivative |
| 04/04/2007 | CA2570755A1 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 04/03/2007 | US7199229 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |